Back to Search
Start Over
CML may not be part of HUS.
- Source :
-
American journal of hematology [Am J Hematol] 1995 May; Vol. 49 (1), pp. 100-1. - Publication Year :
- 1995
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols
Bone Marrow Transplantation
Disease Progression
Granulocyte-Macrophage Colony-Stimulating Factor therapeutic use
Hemolytic-Uremic Syndrome chemically induced
Humans
Hydroxyurea therapeutic use
Interferon Type I adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive physiopathology
Male
Middle Aged
Recombinant Proteins
Transplantation, Autologous
Hemolytic-Uremic Syndrome etiology
Interferon-alpha adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive therapy
Subjects
Details
- Language :
- English
- ISSN :
- 0361-8609
- Volume :
- 49
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- American journal of hematology
- Publication Type :
- Report
- Accession number :
- 7741131
- Full Text :
- https://doi.org/10.1002/ajh.2830490124